Salacia reticulata is a climbing plant used to soften after-meal blood sugar spikes by slowing carbohydrate digestion. It modestly lowers fasting and long-term blood sugar in early or established type 2 diabetes; with normal blood sugar, the expected gain is smaller and less certain. Expected side effects are gas and bloating; blood sugar can fall too low with insulin or certain oral diabetes drugs. Evidence is small, short-term, often company-linked. (Full Review)
| Marker | Target | Why |
|---|---|---|
| HbA1c | 4.0–5.6% (standard reference range) | Primary trial outcome |
| Fasting plasma glucose | 70–99 mg/dL (standard reference range) | Expected to change |
| Post-meal glucose (continuous glucose monitor) | No established target; track peak rise and 2-hour return versus own baseline meals | Direct readout of the mechanism |
| LDL cholesterol | <100 mg/dL (standard reference range) | Expected to change |
| Triglycerides | <150 mg/dL (standard reference range) | Expected to change |
| Glucose during low-sugar symptoms | At or above 70 mg/dL | Safety check for sulfonylurea or insulin users |
Cadence: Baseline HbA1c, fasting glucose and lipid panel; post-meal glucose checks during the first 1–2 weeks, fasting glucose and lipids at 6 weeks, HbA1c at 3 months, then every 6–12 months